Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Peter A. W. te Boekhorst"'
Autor:
Bjorn Andreasson, Peter L. Johansson, Federico Sackmann, Giovanni Barosi, Zhijian Xiao, Françoise Boyer, Ruben A. Mesa, Suzan Commandeur, Carlos Besses, Tiziano Barbui, Norman Maldonado, Maria Luisa Ferrari, Peter A. W. te Boekhorst, Francisco Cervantes, Jean-Jacques Kiladjian, Yue Zhang, Zhenya Senyak, Harry C. Schouten, Karin Bonatz, Konstanze Döhner, Dana Ranta, Zefeng Xu, Jan Samuelsson, Jean-Yves Cahn, Francesco Passamonti, Deepti Radia, Andreas Reiter, Sonja Zweegman, Xiujuan Sun, Alessandro Rambaldi, Ana Kerguelen Fuentes, Junqing Xu, Thomas Lehmann, Lydia Roy, Gabriel Etienne, Alessandro M. Vannucchi, Heidi E. Kosiorek, Jean Christophe Ianotto, Martin Griesshammer, Peihong Zhang, Robert Peter Gale, Heike L. Pahl, Gunnar Birgegård, Claire N. Harrison, Frank Stegelmann, Robyn M. Scherber, Pablo J. Muxi, Stefanie Slot, Dolores Hernández-Maraver, Amylou C. Dueck, Holly L. Geyer
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, 2016, 34 (2), pp.151-9. ⟨10.1200/JCO.2015.62.9337⟩
Geyer, H, Scherber, R, Kosiorek, H, Dueck, A C, Kiladjian, J-J, Xiao, Z, Slot, S, Zweegman, S, Sackmann, F, Kerguelen Fuentes, A, Hernandez-Maraver, D, Doehner, K, Harrison, C N, Radia, D, Muxi, P, Besses, C, Cervantes, F, Johansson, P L, Andreasson, B, Rambaldi, A, Barbui, T, Bonatz, K, Reiter, A, Boyer, F, Etienne, G, Ianotto, J-C, Ranta, D, Roy, L, Cahn, J-Y, Maldonado, N, Barosi, G, Ferrari, M L, Gale, R P, Birgegard, G, Xu, Z, Zhang, Y, Sun, X, Xu, J, Zhang, P, te Boekhorst, P A W, Commandeur, S, Schouten, H, Pahl, H L, Griesshammer, M, Stegelmann, F, Lehmann, T, Senyak, Z, Vannucchi, A M, Passamonti, F, Samuelsson, J & Mesa, R A 2016, ' Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease ', Journal of Clinical Oncology, vol. 34, no. 2, pp. 151-+ . https://doi.org/10.1200/JCO.2015.62.9337
Journal of Clinical Oncology, 34(2), 151-+. American Society of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2016, 34 (2), pp.151-9. ⟨10.1200/JCO.2015.62.9337⟩
Journal of Clinical Oncology, 2016, 34 (2), pp.151-9. ⟨10.1200/JCO.2015.62.9337⟩
Geyer, H, Scherber, R, Kosiorek, H, Dueck, A C, Kiladjian, J-J, Xiao, Z, Slot, S, Zweegman, S, Sackmann, F, Kerguelen Fuentes, A, Hernandez-Maraver, D, Doehner, K, Harrison, C N, Radia, D, Muxi, P, Besses, C, Cervantes, F, Johansson, P L, Andreasson, B, Rambaldi, A, Barbui, T, Bonatz, K, Reiter, A, Boyer, F, Etienne, G, Ianotto, J-C, Ranta, D, Roy, L, Cahn, J-Y, Maldonado, N, Barosi, G, Ferrari, M L, Gale, R P, Birgegard, G, Xu, Z, Zhang, Y, Sun, X, Xu, J, Zhang, P, te Boekhorst, P A W, Commandeur, S, Schouten, H, Pahl, H L, Griesshammer, M, Stegelmann, F, Lehmann, T, Senyak, Z, Vannucchi, A M, Passamonti, F, Samuelsson, J & Mesa, R A 2016, ' Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease ', Journal of Clinical Oncology, vol. 34, no. 2, pp. 151-+ . https://doi.org/10.1200/JCO.2015.62.9337
Journal of Clinical Oncology, 34(2), 151-+. American Society of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2016, 34 (2), pp.151-9. ⟨10.1200/JCO.2015.62.9337⟩
Purpose Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) associated with disabling symptoms and a heightened risk of life-threatening complications. Recent studies have demonstrated the effectiveness of JAK inhibitor therapy in patients